Elizabeth Ann Winzeler is a Professor in the Department of Pediatrics at University of California, San Diego, School of Medicine with experience in academic and industrial antimicrobial drug discovery.
She received her Ph.D. in 1996 from the Department of Developmental Biology at Stanford University, training under the microbiologist, Lucy Shapiro. She also performed postdoctoral studies at Stanford working with the geneticist, Ronald Davis, before moving to a joint position at the Scripps Research Institute and the Genomics Institute of the Novartis Research Foundation in 1999. At the Genomics Institute of the Novartis Research Foundation she led a malaria drug discovery program that has yielded several novel antimalarial chemotypes that are currently in clinical trials (KAE609, also known as cipargamin, and KAF179). In 2012 she moved to the University of California, San Diego where she leads a group that uses systematic, data intensive methods to solve problems at the interface of host pathogen biology typically involving large collections of chemical screening data and whole genome sequencing.
She has received prestigious awards from the Keck Foundation, the Ellison Medical Foundation, and the Bill and Melinda Gates Foundation and was a semifinalist in the 2008 Howard Hughes Competition. In 2014 she was awarded the Bailey-Ashford Medal for distinguished achievements in tropical medicine. She has authored over 110 publications that have been collectively cited more than 18,000 times.